分子細胞遺伝学市場規模、シェア、動向分析レポート：用途別、技術別、製品別、最終用途別、地域別、セグメント予測、2025年～2033年

分子細胞遺伝学市場の概要

世界の分子細胞遺伝学市場規模は2024年に24億米ドルと推定され、2025～2033年にかけてCAGR 11.7%で成長し、2033年には63億9,000万米ドルに達すると予測されます。市場拡大を支えているのは、臨床診断や研究、特に腫瘍学、遺伝性疾患、出生前検査における分子細胞遺伝学的手法の利用の増加です。

これらのツールは染色体異常の高解像度分析を提供し、最新の検査室と臨床ワークフローに不可欠なものとなっています。蛍光in situハイブリダイゼーション（FISH）、比較ゲノムハイブリダイゼーション（CGH）、アレイベース手法の応用が拡大していることも、分子細胞遺伝学の採用拡大に寄与しています。個別化医療での使用拡大、自動化と画像化における技術向上は、病院、学術機関、研究センター全体の市場需要を引き続き強化しています。

ゲノムデータ量の増加に伴い、マルチオミクスアプローチの統合とバイオインフォマティクスツールの進歩が分子細胞遺伝学セグメントを大幅に強化しています。これらの機能強化により、大規模なゲノムデータセットの管理、分析、解釈が容易になり、染色体変化と疾患との有意な関連性の発見が容易になります。その結果、分子細胞遺伝学の需要は拡大することが予想され、ラボは研究と診断の両方の用途でこれらのツールへの依存を強めています。

2023年12月、ルピン・ダイアグノスティックスはタミル・ナードゥ州チェンナイに最新鋭の地域リファレンスラボを開設しました。このラボでは、フローサイトメトリー、細胞診などと並んで、分子診断学、特に細胞遺伝学を含む幅広いサービスを提供しています。この拡大により、高品質な分子細胞遺伝学検査への地域アクセスが強化され、インド南部における診断能力の向上がサポートされます。大手診断プロバイダによるこのような投資は、日常臨床における細胞遺伝学の重要性を検証し、この技術の有用性と将来の成長可能性に対する市場の信頼の高まりを反映しています。

目次

第1章 分子細胞遺伝学市場：調査手法と範囲

第2章 分子細胞遺伝学市場：エグゼクティブサマリー

• 市場展望
• アプリケーションと技術のスナップショット
• 製品と最終用途のスナップショット
• 競合情勢のスナップショット

第3章 分子細胞遺伝学市場：市場変数、動向、範囲

• 市場系統の展望
• 市場力学
• 産業分析ツール

第4章 分子細胞遺伝学市場：用途ビジネス分析

• 分子細胞遺伝学市場：用途変動分析
• 遺伝性疾患
• 腫瘍学
• パーソナライズ医療
• その他

第5章 分子細胞遺伝学市場：技術ビジネス分析

• 分子細胞遺伝学市場：技術変動分析
• 比較ゲノムハイブリダイゼーション
• FISH
• 免疫組織化学
• 核型分析
• その他

第6章 分子細胞遺伝学市場：製品ビジネス分析

• 分子細胞遺伝学市場：製品変動分析
• 機器
• 消耗品
• ソフトウェアとサービス

第7章 分子細胞遺伝学市場：最終用途ビジネス分析

• 分子細胞遺伝学市場：最終用途変動分析
• 臨床ラボ
• 病院と病理検査室
• 学術研究機関
• 製薬バイオテクノロジー企業
• その他

第7章 分子細胞遺伝学市場：地域ビジネス分析

• 地域市場のスナップショット
• 北米
• 欧州
• アジア太平洋
• ラテンアメリカ
• 中東・アフリカ

第8章 分子細胞遺伝学市場：競合情勢

• 企業分類
• 戦略マッピング
• 企業市場シェア分析、2024年
• 企業プロファイル

List of Tables

• Table 1 List of Secondary Sources
• Table 2 List of Abbreviation
• Table 3 Global Molecular Cytogenetics Market, By Region, 2021 - 2030 (USD Million)
• Table 4 Global Molecular Cytogenetics Market, By Application, 2021 - 2030 (USD Million)
• Table 5 Global Molecular Cytogenetics Market, By Product, 2021 - 2030 (USD Million)
• Table 6 Global Molecular Cytogenetics Market, By Technology, 2021 - 2030 (USD Million)
• Table 7 Global Molecular Cytogenetics Market, By End Use, 2021 - 2030 (USD Million)
• Table 8 North America Molecular Cytogenetics Market, By Country, 2021 - 2030 (USD Million)
• Table 9 North America Molecular Cytogenetics Market, By Application, 2021 - 2030 (USD Million)
• Table 10 North America Molecular Cytogenetics Market, By Product, 2021 - 2030 (USD Million)
• Table 11 North America Molecular Cytogenetics Market, By Technology, 2021 - 2030 (USD Million)
• Table 12 North America Molecular Cytogenetics Market, By End Use, 2021 - 2030 (USD Million)
• Table 13 U.S. Molecular Cytogenetics Market, by Application, 2021 - 2030 (USD Million)
• Table 14 U.S. Molecular Cytogenetics Market, By Product, 2021 - 2030 (USD Million)
• Table 15 U.S. Molecular Cytogenetics Market, By Technology, 2021 - 2030 (USD Million)
• Table 16 U.S. Molecular Cytogenetics Market, By End Use, 2021 - 2030 (USD Million)
• Table 17 Canada Molecular Cytogenetics Market, By Application, 2021 - 2030 (USD Million)
• Table 18 Canada Molecular Cytogenetics Market, by Product, 2021 - 2030 (USD Million)
• Table 19 Canada Molecular Cytogenetics Market, by Technology, 2021 - 2030 (USD Million)
• Table 20 Canada Molecular Cytogenetics Market, By End Use, 2021 - 2030 (USD Million)
• Table 21 Mexico Molecular Cytogenetics Market, by Application, 2021 - 2030 (USD Million)
• Table 22 Mexico Molecular Cytogenetics Market, By Product, 2021 - 2030 (USD Million)
• Table 23 Mexico Molecular Cytogenetics Market, By Technology, 2021 - 2030 (USD Million)
• Table 24 Mexico Molecular Cytogenetics Market, By End Use, 2021 - 2030 (USD Million)
• Table 25 Europe Molecular Cytogenetics Market, by country, 2021 - 2030 (USD Million)
• Table 26 Europe Molecular Cytogenetics Market, by Application, 2021 - 2030 (USD Million)
• Table 27 Europe Molecular Cytogenetics Market, By Product, 2021 - 2030 (USD Million)
• Table 28 Europe Molecular Cytogenetics Market, By Technology, 2021 - 2030 (USD Million)
• Table 29 Europe Molecular Cytogenetics Market, By End Use, 2021 - 2030 (USD Million)
• Table 30 UK Molecular Cytogenetics Market, by Application, 2021 - 2030 (USD Million)
• Table 31 UK Molecular Cytogenetics Market, By Product, 2021 - 2030 (USD Million)
• Table 32 UK Molecular Cytogenetics Market, By Technology, 2021 - 2030 (USD Million)
• Table 33 UK Molecular Cytogenetics Market, By End Use, 2021 - 2030 (USD Million)
• Table 34 Germany Molecular Cytogenetics Market, by Application, 2021 - 2030 (USD Million)
• Table 35 Germany Molecular Cytogenetics Market, By Product, 2021 - 2030 (USD Million)
• Table 36 Germany Molecular Cytogenetics Market, By Technology, 2021 - 2030 (USD Million)
• Table 37 Germany Molecular Cytogenetics Market, By End Use, 2021 - 2030 (USD Million)
• Table 38 France Molecular Cytogenetics Market, by Application, 2021 - 2030 (USD Million)
• Table 39 France Molecular Cytogenetics Market, By Product, 2021 - 2030 (USD Million)
• Table 40 France Molecular Cytogenetics Market, By Technology, 2021 - 2030 (USD Million)
• Table 41 France Molecular Cytogenetics Market, By End Use, 2021 - 2030 (USD Million)
• Table 42 Italy Molecular Cytogenetics Market, by Application, 2021 - 2030 (USD Million)
• Table 43 Italy Molecular Cytogenetics Market, By Product, 2021 - 2030 (USD Million)
• Table 44 Italy Molecular Cytogenetics Market, By Technology, 2021 - 2030 (USD Million)
• Table 45 Italy Molecular Cytogenetics Market, By End Use, 2021 - 2030 (USD Million)
• Table 46 Spain Molecular Cytogenetics Market, by Application, 2021 - 2030 (USD Million)
• Table 47 Spain Molecular Cytogenetics Market, By Product, 2021 - 2030 (USD Million)
• Table 48 Spain Molecular Cytogenetics Market, By Technology, 2021 - 2030 (USD Million)
• Table 49 Spain Molecular Cytogenetics Market, By End Use, 2021 - 2030 (USD Million)
• Table 50 Sweden Molecular Cytogenetics Market, by Application, 2021 - 2030 (USD Million)
• Table 51 Sweden Molecular Cytogenetics Market, By Product, 2021 - 2030 (USD Million)
• Table 52 Sweden Molecular Cytogenetics Market, By Technology, 2021 - 2030 (USD Million)
• Table 53 Sweden Molecular Cytogenetics Market, By End Use, 2021 - 2030 (USD Million)
• Table 54 Norway Molecular Cytogenetics Market, by Application, 2021 - 2030 (USD Million)
• Table 55 Norway Molecular Cytogenetics Market, By Product, 2021 - 2030 (USD Million)
• Table 56 Norway Molecular Cytogenetics Market, By Technology, 2021 - 2030 (USD Million)
• Table 57 Norway Molecular Cytogenetics Market, By End Use, 2021 - 2030 (USD Million)
• Table 58 Denmark Molecular Cytogenetics Market, by Application, 2021 - 2030 (USD Million)
• Table 59 Denmark Molecular Cytogenetics Market, By Product, 2021 - 2030 (USD Million)
• Table 60 Denmark Molecular Cytogenetics Market, By Technology, 2021 - 2030 (USD Million)
• Table 61 Denmark Molecular Cytogenetics Market, By End Use, 2021 - 2030 (USD Million)
• Table 62 Asia Pacific Molecular Cytogenetics Market, by country, 2021 - 2030 (USD Million)
• Table 63 Asia Pacific Molecular Cytogenetics Market, by Application, 2021 - 2030 (USD Million)
• Table 64 Asia Pacific Molecular Cytogenetics Market, By Product, 2021 - 2030 (USD Million)
• Table 65 Asia Pacific Molecular Cytogenetics Market, By Technology, 2021 - 2030 (USD Million)
• Table 66 Asia Pacific Molecular Cytogenetics Market, By End Use, 2021 - 2030 (USD Million)
• Table 67 Japan Molecular Cytogenetics Market, by Application, 2021 - 2030 (USD Million)
• Table 68 Japan Molecular Cytogenetics Market, By Product, 2021 - 2030 (USD Million)
• Table 69 Japan Molecular Cytogenetics Market, By Technology, 2021 - 2030 (USD Million)
• Table 70 Japan Molecular Cytogenetics Market, By End Use, 2021 - 2030 (USD Million)
• Table 71 China Molecular Cytogenetics Market, by Application, 2021 - 2030 (USD Million)
• Table 72 China Molecular Cytogenetics Market, By Product, 2021 - 2030 (USD Million)
• Table 73 China Molecular Cytogenetics Market, By Technology, 2021 - 2030 (USD Million)
• Table 74 China Molecular Cytogenetics Market, By End Use, 2021 - 2030 (USD Million)
• Table 75 India Molecular Cytogenetics Market, by Application, 2021 - 2030 (USD Million)
• Table 76 India Molecular Cytogenetics Market, By Product, 2021 - 2030 (USD Million)
• Table 77 India Molecular Cytogenetics Market, By Technology, 2021 - 2030 (USD Million)
• Table 78 India Molecular Cytogenetics Market, By End Use, 2021 - 2030 (USD Million)
• Table 79 Australia Molecular Cytogenetics Market, by Application, 2021 - 2030 (USD Million)
• Table 80 Australia Molecular Cytogenetics Market, By Product, 2021 - 2030 (USD Million)
• Table 81 Australia Molecular Cytogenetics Market, By Technology, 2021 - 2030 (USD Million)
• Table 82 Australia Molecular Cytogenetics Market, By End Use, 2021 - 2030 (USD Million)
• Table 83 Thailand Molecular Cytogenetics Market, by Application, 2021 - 2030 (USD Million)
• Table 84 Thailand Molecular Cytogenetics Market, By Product, 2021 - 2030 (USD Million)
• Table 85 Thailand Molecular Cytogenetics Market, By Technology, 2021 - 2030 (USD Million)
• Table 86 Thailand Molecular Cytogenetics Market, By End Use, 2021 - 2030 (USD Million)
• Table 87 South Korea Molecular Cytogenetics Market, by Application, 2021 - 2030 (USD Million)
• Table 88 South Korea Molecular Cytogenetics Market, By Product, 2021 - 2030 (USD Million)
• Table 89 South Korea Molecular Cytogenetics Market, By Technology, 2021 - 2030 (USD Million)
• Table 90 South Korea Molecular Cytogenetics Market, By End Use, 2021 - 2030 (USD Million)
• Table 91 Latin America Molecular Cytogenetics Market, by country, 2021 - 2030 (USD Million)
• Table 92 Latin America Molecular Cytogenetics Market, by Application, 2021 - 2030 (USD Million)
• Table 93 Latin America Molecular Cytogenetics Market, By Product, 2021 - 2030 (USD Million)
• Table 94 Latin America Molecular Cytogenetics Market, By Technology, 2021 - 2030 (USD Million)
• Table 95 Latin America Molecular Cytogenetics Market, By End Use, 2021 - 2030 (USD Million)
• Table 96 Brazil Molecular Cytogenetics Market, by Application, 2021 - 2030 (USD Million)
• Table 97 Brazil Molecular Cytogenetics Market, By Product, 2021 - 2030 (USD Million)
• Table 98 Brazil Molecular Cytogenetics Market, By Technology, 2021 - 2030 (USD Million)
• Table 99 Brazil Molecular Cytogenetics Market, By End Use, 2021 - 2030 (USD Million)
• Table 100 Argentina Molecular Cytogenetics Market, by Application, 2021 - 2030 (USD Million)
• Table 101 Argentina Molecular Cytogenetics Market, By Product, 2021 - 2030 (USD Million)
• Table 102 Argentina Molecular Cytogenetics Market, By Technology, 2021 - 2030 (USD Million)
• Table 103 Argentina Molecular Cytogenetics Market, By End Use, 2021 - 2030 (USD Million)
• Table 104 MEA Molecular Cytogenetics Market, by country, 2021 - 2030 (USD Million)
• Table 105 MEA Molecular Cytogenetics Market, by Application, 2021 - 2030 (USD Million)
• Table 106 MEA Molecular Cytogenetics Market, By Product, 2021 - 2030 (USD Million)
• Table 107 MEA Molecular Cytogenetics Market, By Technology, 2021 - 2030 (USD Million)
• Table 108 MEA Molecular Cytogenetics Market, By End Use, 2021 - 2030 (USD Million)
• Table 109 South Africa Molecular Cytogenetics Market, by Application, 2021 - 2030 (USD Million)
• Table 110 South Africa Molecular Cytogenetics Market, By Product, 2021 - 2030 (USD Million)
• Table 111 South Africa Molecular Cytogenetics Market, By Technology, 2021 - 2030 (USD Million)
• Table 112 South Africa Molecular Cytogenetics Market, By End Use, 2021 - 2030 (USD Million)
• Table 113 Saudi Arabia Molecular Cytogenetics Market, by Application, 2021 - 2030 (USD Million)
• Table 114 Saudi Arabia Molecular Cytogenetics Market, By Product, 2021 - 2030 (USD Million)
• Table 115 Saudi Arabia Molecular Cytogenetics Market, By Technology, 2021 - 2030 (USD Million)
• Table 116 Saudi Arabia Molecular Cytogenetics Market, By End Use, 2021 - 2030 (USD Million)
• Table 117 UAE Molecular Cytogenetics Market, by Application, 2021 - 2030 (USD Million)
• Table 118 UAE Molecular Cytogenetics Market, By Product, 2021 - 2030 (USD Million)
• Table 119 UAE Molecular Cytogenetics Market, By Technology, 2021 - 2030 (USD Million)
• Table 120 UAE Molecular Cytogenetics Market, By End Use, 2021 - 2030 (USD Million)
• Table 121 Kuwait Molecular Cytogenetics Market, by Application, 2021-2030, (USD)
• Table 122 Kuwait Molecular Cytogenetics Market, By Product, 2021 - 2030 (USD Million)
• Table 123 Kuwait Molecular Cytogenetics Market, By Technology, 2021 - 2030 (USD Million)
• Table 124 Kuwait Molecular Cytogenetics Market, By End Use, 2021 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Information procurement
• Fig. 3 Market summary
• Fig. 4 Market segmentation & scope
• Fig. 5 Market size and growth prospects
• Fig. 6 Global molecular cytogenetics market- Key market driver analysis
• Fig. 7 Global molecular cytogenetics market - Key market restraint analysis
• Fig. 8 Penetration & growth prospect mapping
• Fig. 9 Global molecular cytogenetics market - Porter's analysis
• Fig. 10 Global molecular cytogenetics market - PESTEL analysis
• Fig. 11 Global molecular cytogenetics market product outlook key takeaways
• Fig. 12 Global molecular cytogenetics market: Product movement analysis
• Fig. 13 Instruments market estimates, 2021 - 2033 (USD Million)
• Fig. 14 Consumables market estimates, 2021 - 2033 (USD Million)
• Fig. 15 Software & Services market estimates, 2021 - 2033 (USD Million)
• Fig. 16 Services market estimates, 2021 - 2033 (USD Million)
• Fig. 17 Global molecular cytogenetics market application outlook key takeaways
• Fig. 18 Global molecular cytogenetics market: application movement analysis
• Fig. 19 Genetic Disorders market estimates, 2021 - 2033 (USD Million)
• Fig. 20 Oncology market estimates, 2021 - 2033 (USD Million)
• Fig. 21 Personalized Medicine market estimates, 2021 - 2033 (USD Million)
• Fig. 22 Other Application market estimates, 2021 - 2033 (USD Million)
• Fig. 23 Global molecular cytogenetics market technology outlook key takeaways
• Fig. 24 Global molecular cytogenetics market: technology movement analysis
• Fig. 25 Comparative Genomic Hybridisation market estimates, 2021 - 2033 (USD Million)
• Fig. 26 aCGH market estimates, 2021 - 2033 (USD Million)
• Fig. 27 sCGH market estimates, 2021 - 2033 (USD Million)
• Fig. 28 FISH market estimates, 2021 - 2033 (USD Million)
• Fig. 29 Immunohistochemistry market estimates, 2021 - 2033 (USD Million)
• Fig. 30 Karyotyping market estimates, 2021 - 2033 (USD Million)
• Fig. 31 Spectral market estimates, 2021 - 2033 (USD Million)
• Fig. 32 Virtual market estimates, 2021 - 2033 (USD Million)
• Fig. 33 Others market estimates, 2021 - 2033 (USD Million)
• Fig. 34 Global molecular cytogenetics market End use outlook key takeaways
• Fig. 35 Global molecular cytogenetics market: End use movement analysis
• Fig. 36 Comparative Genomic Hybridisation market estimates, 2021 - 2033 (USD Million)
• Fig. 37 Clinical & Research Laboratories market estimates, 2021 - 2033 (USD Million)
• Fig. 38 Hospitals & Path Labs market estimates, 2021 - 2033 (USD Million)
• Fig. 39 Academic Research Institutes market estimates, 2021 - 2033 (USD Million)
• Fig. 40 Pharmaceutical & Biotech Companies market estimates, 2021 - 2033 (USD Million)
• Fig. 41 Others market estimates, 2021 - 2033 (USD Million)
• Fig. 42 Regional marketplace: Key takeaways
• Fig. 43 Global molecular cytogenetics market: Regional movement analysis
• Fig. 44 North America molecular cytogenetics market, 2021 - 2033 (USD Million)
• Fig. 45 U.S. molecular cytogenetics market, 2021 - 2033 (USD Million)
• Fig. 46 Canada molecular cytogenetics market, 2021 - 2033 (USD Million)
• Fig. 47 Mexico molecular cytogenetics market, 2021 - 2033 (USD Million)
• Fig. 48 Europe molecular cytogenetics market, 2021 - 2033 (USD Million)
• Fig. 49 UK molecular cytogenetics market, 2021 - 2033 (USD Million)
• Fig. 50 Germany molecular cytogenetics market, 2021 - 2033 (USD Million)
• Fig. 51 France molecular cytogenetics market, 2021 - 2033 (USD Million)
• Fig. 52 Spain molecular cytogenetics market, 2021 - 2033 (USD Million)
• Fig. 53 Italy molecular cytogenetics market, 2021 - 2033 (USD Million)
• Fig. 54 Denmark molecular cytogenetics market, 2021 - 2033 (USD Million)
• Fig. 55 Sweden molecular cytogenetics market, 2021 - 2033 (USD Million)
• Fig. 56 Norway molecular cytogenetics market, 2021 - 2033 (USD Million)
• Fig. 57 Asia Pacific molecular cytogenetics market, 2021 - 2033 (USD Million)
• Fig. 58 Japan molecular cytogenetics market, 2021 - 2033 (USD Million)
• Fig. 59 China molecular cytogenetics market, 2021 - 2033 (USD Million)
• Fig. 60 India molecular cytogenetics market, 2021 - 2033 (USD Million)
• Fig. 61 South Korea molecular cytogenetics market, 2021 - 2033 (USD Million)
• Fig. 62 Australia molecular cytogenetics market, 2021 - 2033 (USD Million)
• Fig. 63 Thailand molecular cytogenetics market, 2021 - 2033 (USD Million)
• Fig. 64 Latin America molecular cytogenetics market, 2021 - 2033 (USD Million)
• Fig. 65 Brazil molecular cytogenetics market, 2021 - 2033 (USD Million)
• Fig. 66 Argentina molecular cytogenetics market, 2021 - 2033 (USD Million)
• Fig. 67 MEA molecular cytogenetics market, 2021 - 2033 (USD Million)
• Fig. 68 South Africa molecular cytogenetics market, 2021 - 2033 (USD Million)
• Fig. 69 Saudi Arabia molecular cytogenetics market, 2021 - 2033 (USD Million)
• Fig. 70 UAE molecular cytogenetics market, 2021 - 2033 (USD Million)
• Fig. 71 Kuwait molecular cytogenetics market, 2021 - 2033 (USD Million)
• Fig. 72 Strategy framework

Molecular Cytogenetics Market Summary

The global molecular cytogenetics market size was estimated at USD 2.40 billion in 2024 and is projected to reach USD 6.39 billion by 2033, growing at a CAGR of 11.7% from 2025 to 2033. The market expansion is supported by the increasing use of molecular cytogenetic techniques in clinical diagnostics and research, particularly in oncology, genetic disorders, and prenatal testing.

These tools offer high-resolution analysis of chromosomal abnormalities, making them essential in modern laboratory and clinical workflows. The growing application of fluorescence in situ hybridization (FISH), comparative genomic hybridization (CGH), and array-based methods contributes to the rising adoption of molecular cytogenetics. Expanding use in personalized medicine and technological improvements in automation and imaging continue to strengthen market demand across hospitals, academic institutions, and research centers.

With the growing volume of genomic data, integrating multi-omics approaches and advancements in bioinformatics tools significantly enhances the molecular cytogenetics field. These enhancements facilitate better management, analysis, and interpretation of large genomic datasets, making it easier to discover meaningful links between chromosomal alterations and diseases. As a result, demand for molecular cytogenetics is expected to grow, with laboratories increasingly relying on these tools for both research and diagnostic applications.

In December 2023, Lupin Diagnostics unveiled a new state-of-the-art Regional Reference Laboratory in Chennai, Tamil Nadu. This laboratory offers a wide range of services, including molecular diagnostics and especially cytogenetics, alongside flow cytometry, cytology, and more. This expansion enhances regional access to high-quality molecular cytogenetic testing and supports better diagnostic capabilities in southern India. Such investments by major diagnostic providers validate cytogenetics' significance in routine clinical practice and reflect growing market confidence in the technology's utility and future growth potential.

Global Molecular Cytogenetics Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global molecular cytogenetics market based on application, technology, product, end use, and region:

• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Genetic Disorders
• Oncology
• Personalized Medicine
• Other Applications
• Technology Outlook (Revenue, USD Million, 2021 - 2033)
• Comparative Genomic Hybridization
  • aCGH
  • sCGH
• FISH
• Immunohistochemistry
• Karyotyping
  • Spectral
  • Virtual
• Others
• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Instruments
• Consumables
• Software & Services
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Clinical & Research Laboratories
• Hospitals & Path Labs
• Academic Research Institutes
• Pharmaceutical & Biotech Companies
• Others
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1 Molecular Cytogenetics Market: Research Methodology And Scope

• 1.1 Market Segmentation And Scope
  • 1.1.1 Segment Definitions
    • 1.1.1.1 Application Segment
    • 1.1.1.2 Technology Segment
    • 1.1.1.3 Product Segment
    • 1.1.1.4 End Use Segment
• 1.2 Regional Scope
• 1.3 Estimates And Forecast Timeline
• 1.4 Objectives
  • 1.4.1 Objective - 1
  • 1.4.2 Objective - 2
  • 1.4.3 Objective - 3
• 1.5 Research Methodology
• 1.6 Information Procurement
  • 1.6.1 Purchased Database
  • 1.6.2 Gvr's Internal Database
  • 1.6.3 Secondary Sources
  • 1.6.4 Primary Research
• 1.7 Information Or Data Analysis
  • 1.7.1 Data Analysis Models
• 1.8 Market Formulation & Validation
• 1.9 Model Details
  • 1.9.1 Commodity Flow Analysis
• 1.10 List Of Secondary Sources
• 1.11 List Of Abbreviations

Chapter 2 Molecular Cytogenetics Market: Executive Summary

• 2.1 Market Outlook
• 2.2 Application And Technology Snapshot
• 2.3 Product And End Use Snapshot
• 2.4 Competitive Landscape Snapshot

Chapter 3 Molecular Cytogenetics Market: Market Variables, Trends & Scope

• 3.1 Market Lineage Outlook
  • 3.1.1 Related/Ancillary Market Outlook
• 3.2 Market Dynamics
  • 3.2.1 Market Drivers Analysis
    • 3.2.1.1 Rapid Technological Advancements
    • 3.2.1.2 Increasing Prevalence Of Genetic Disorders
    • 3.2.1.3 Growing Application In Oncology
    • 3.2.1.4 Increasing Demand For Personalized Medicine
  • 3.2.2 Market Restraint Analysis
    • 3.2.2.1 High Costs Of Testing
    • 3.2.2.2 Lack Of Reimbursement Policies
• 3.3 Industry Analysis Tools
  • 3.3.1 Porter's Analysis
  • 3.3.2 Pestel Analysis

Chapter 4 Molecular Cytogenetics Market: Application Business Analysis

• 4.1 Molecular Cytogenetics Market: Application Movement Analysis
• 4.2 Genetic Disorders
  • 4.2.1 Genetic Disorders Market Estimates And Forecast, 2021 - 2033 (USD Million)
• 4.3 Oncology
  • 4.3.1 Oncology Market Estimates And Forecast, 2021 - 2033 (USD Million)
• 4.4 Personalized Medicine
  • 4.4.1 Personalized Medicine Market Estimates And Forecast, 2021 - 2033 (USD Million)
• 4.5 Other Application
  • 4.5.1 Other Application Market Estimates And Forecast, 2021 - 2033 (USD Million)

Chapter 5 Molecular Cytogenetics Market: Technology Business Analysis

• 5.1 Molecular Cytogenetics Market: Technology Movement Analysis
• 5.2 Comparative Genomic Hybridisation
  • 5.2.1 Comparative Genomic Hybridisation Market Estimates And Forecast, 2021 - 2033 (USD Million)
  • 5.2.2 Acgh
    • 5.2.2.1 Acgh Market Estimates And Forecast, 2021 - 2033 (USD Million)
  • 5.2.3 Scgh
    • 5.2.3.1 Scgh Market Estimates And Forecast, 2021 - 2033 (USD Million)
• 5.3 Fish
  • 5.3.1 Fish Market Estimates And Forecast, 2021 - 2033 (USD Million)
• 5.4 Immunohistochemistry
  • 5.4.1 Immunohistochemistry Market Estimates And Forecast, 2021 - 2033 (USD Million)
• 5.5 Karyotyping
  • 5.5.1 Karyotyping Market Estimates And Forecast, 2021 - 2033 (USD Million)
  • 5.5.2 Spectral
    • 5.5.2.1 Spectral Market Estimates And Forecast, 2021 - 2033 (USD Million)
  • 5.5.3 Virtual
    • 5.5.3.1 Virtual Market Estimates And Forecast, 2021 - 2033 (USD Million)
• 5.6 Others
  • 5.6.1 Others Market Estimates And Forecast, 2021 - 2033 (USD Million)

Chapter 6 Molecular Cytogenetics Market: Product Business Analysis

• 6.1 Molecular Cytogenetics Market: Product Movement Analysis
• 6.2 Instruments
  • 6.2.1 Instruments Market Estimates And Forecast, 2021 - 2033 (USD Million)
• 6.3 Consumables
  • 6.3.1 Consumables Market Estimates And Forecast, 2021 - 2033 (USD Million)
• 6.4 Software & Services
  • 6.4.1 Software & Services Market Estimates And Forecast, 2021 - 2033 (USD Million)

Chapter 7 Molecular Cytogenetics Market: End Use Business Analysis

• 7.1 Molecular Cytogenetics Market: End Use Movement Analysis
• 7.2 Clinical & Research Laboratories
  • 7.2.1 Clinical & Research Laboratories Market Estimates And Forecast, 2021 - 2033 (USD Million)
• 7.3 Hospitals & Path Labs
  • 7.3.1 Hospitals & Path Labs Market Estimates And Forecast, 2021 - 2033 (USD Million)
• 7.4 Academic Research Institutes
  • 7.4.1 Academic Research Institutes Market Estimates And Forecast, 2021 - 2033 (USD Million)
• 7.5 Pharmaceutical & Biotech Companies
  • 7.5.1 Pharmaceutical & Biotech Companies Market Estimates And Forecast, 2021 - 2033 (USD Million)
• 7.6 Others
  • 7.6.1 Others Market Estimates And Forecast, 2021 - 2033 (USD Million)

Chapter 7 Molecular Cytogenetics Market: Regional Business Analysis

• 7.1 Regional Market Snapshot
• 7.2 North America
  • 7.2.1 North America Molecular Cytogenetics Market Estimates And Forecast, 2021 - 2033 (USD Million)
  • 7.2.2 U.S.
    • 7.2.2.1 U.S. Molecular Cytogenetics Market, 2021 - 2033 (USD Million)
    • 7.2.2.2 Key Country Dynamics
    • 7.2.2.3 Regulatory Framework
    • 7.2.2.4 Reimbursement Scenario
  • 7.2.3 Canada
    • 7.2.3.1 Canada Molecular Cytogenetics Market, 2021 - 2033 (USD Million)
    • 7.2.3.2 Key Country Dynamics
    • 7.2.3.3 Regulatory Framework
    • 7.2.3.4 Reimbursement Scenario
• 7.3 Europe
  • 7.3.1 Europe Molecular Cytogenetics Market, 2021 - 2033 (USD Million)
  • 7.3.2 UK
    • 7.3.2.1 UK Molecular Cytogenetics Market, 2021 - 2033 (USD Million)
    • 7.3.2.2 Key Country Dynamics
    • 7.3.2.3 Regulatory Framework
    • 7.3.2.4 Reimbursement Scenario
  • 7.3.3 Germany
    • 7.3.3.1 Germany Molecular Cytogenetics Market, 2021 - 2033 (USD Million)
    • 7.3.3.2 Key Country Dynamics
    • 7.3.3.3 Regulatory Framework
    • 7.3.3.4 Reimbursement Scenario
  • 7.3.4 Spain
    • 7.3.4.1 Spain Molecular Cytogenetics Market, 2021 - 2033 (USD Million)
    • 7.3.4.2 Key Country Dynamics
    • 7.3.4.3 Regulatory Framework
    • 7.3.4.4 Reimbursement Scenario
  • 7.3.5 France
    • 7.3.5.1 France Molecular Cytogenetics Market, 2021 - 2033 (USD Million)
    • 7.3.5.2 Key Country Dynamics
    • 7.3.5.3 Regulatory Framework
    • 7.3.5.4 Reimbursement Scenario
  • 7.3.6 Italy
    • 7.3.6.1 Italy Molecular Cytogenetics Market, 2021 - 2033 (USD Million)
    • 7.3.6.2 Key Country Dynamics
    • 7.3.6.3 Regulatory Framework
    • 7.3.6.4 Reimbursement Scenario
  • 7.3.7 Denmark
    • 7.3.7.1 Denmark Molecular Cytogenetics Market, 2021 - 2033 (USD Million)
    • 7.3.7.2 Key Country Dynamics
    • 7.3.7.3 Regulatory Framework
    • 7.3.7.4 Reimbursement Scenario
  • 7.3.8 Sweden
    • 7.3.8.1 Sweden Molecular Cytogenetics Market, 2021 - 2033 (USD Million)
    • 7.3.8.2 Key Country Dynamics
    • 7.3.8.3 Regulatory Framework
    • 7.3.8.4 Reimbursement Scenario
  • 7.3.9 Norway
    • 7.3.9.1 Norway Molecular Cytogenetics Market, 2021 - 2033 (USD Million)
    • 7.3.9.2 Key Country Dynamics
    • 7.3.9.3 Regulatory Framework
    • 7.3.9.4 Reimbursement Scenario
• 7.4 Asia Pacific
  • 7.4.1 Asia-Pacific Molecular Cytogenetics Market, 2021 - 2033 (USD Million)
  • 7.4.2 Japan
    • 7.4.2.1 Japan Molecular Cytogenetics Market, 2021 - 2033 (USD Million)
    • 7.4.2.2 Key Country Dynamics
    • 7.4.2.3 Regulatory Framework
    • 7.4.2.4 Reimbursement Scenario
  • 7.4.3 China
    • 7.4.3.1 China Molecular Cytogenetics Market, 2021 - 2033 (USD Million)
    • 7.4.3.2 Key Country Dynamics
    • 7.4.3.3 Regulatory Framework
    • 7.4.3.4 Reimbursement Scenario
  • 7.4.4 India
    • 7.4.4.1 India Molecular Cytogenetics Market, 2021 - 2033 (USD Million)
    • 7.4.4.2 Key Country Dynamics
    • 7.4.4.3 Regulatory Framework
    • 7.4.4.4. Reimbursement Scenario
  • 7.4.5 South Korea
    • 7.4.5.1 South Korea Molecular Cytogenetics Market, 2021 - 2033 (USD Million)
    • 7.4.5.2 Key Country Dynamics
    • 7.4.5.3 Regulatory Framework
    • 7.4.5.4 Reimbursement Scenario
  • 7.4.6 Thailand
    • 7.4.6.1 Thailand Molecular Cytogenetics Market, 2021 - 2033 (USD Million)
    • 7.4.6.2 Key Country Dynamics
    • 7.4.6.3 Regulatory Framework
    • 7.4.6.4 Reimbursement Scenario
  • 7.4.7 Australia
    • 7.4.7.1 Australia Molecular Cytogenetics Market, 2021 - 2033 (USD Million)
    • 7.4.7.2 Key Country Dynamics
    • 7.4.7.3 Regulatory Framework
    • 7.4.7.4 Reimbursement Scenario
• 7.5 Latin America
  • 7.5.1 Latin America Molecular Cytogenetics Market, 2021 - 2033 (USD Million)
  • 7.5.2 Brazil
    • 7.5.2.1 Brazil Molecular Cytogenetics Market, 2021 - 2033 (USD Million)
    • 7.5.2.2 Key Country Dynamics
    • 7.5.2.3 Regulatory Framework
    • 7.5.2.4 Reimbursement Scenario
  • 7.5.3 Mexico
    • 7.5.3.1 Mexico Molecular Cytogenetics Market, 2021 - 2033 (USD Million)
    • 7.5.3.2 Key Country Dynamics
    • 7.5.3.3 Regulatory Framework
    • 7.5.2.4 Reimbursement Scenario
  • 7.5.4 Argentina
    • 7.5.4.1 Argentina Molecular Cytogenetics Market, 2021 - 2033 (USD Million)
    • 7.5.4.2 Key Country Dynamics
    • 7.5.4.3 Regulatory Framework
    • 7.5.4.4 Reimbursement Scenario
• 7.6 MEA
  • 7.6.1 MEA Molecular Cytogenetics Market, 2021 - 2033 (USD Million)
  • 7.6.2 South Africa
    • 7.6.2.1 South Africa Molecular Cytogenetics Market, 2021 - 2033 (USD Million)
    • 7.6.2.2 Key Country Dynamics
    • 7.6.2.3 Regulatory Framework
    • 7.6.2.4 Reimbursement Scenario
  • 7.6.3 Saudi Arabia
    • 7.6.3.1 Saudi Arabia Molecular Cytogenetics Market, 2021 - 2033 (USD Million)
    • 7.6.3.2 Key Country Dynamics
    • 7.6.3.3 Regulatory Framework
    • 7.6.3.4 Reimbursement Scenario
  • 7.6.4 UAE
    • 7.6.4.1 UAE Molecular Cytogenetics Market, 2021 - 2033 (USD Million)
    • 7.6.4.2 Key Country Dynamics
    • 7.6.4.3 Regulatory Framework
    • 7.6.2.4 Reimbursement Scenario
  • 7.6.5 Kuwait
    • 7.6.5.1 Kuwait Molecular Cytogenetics Market, 2021 - 2033 (USD Million)
    • 7.6.5.2 Key Country Dynamics
    • 7.6.5.3 Regulatory Framework
    • 7.6.5.4 Reimbursement Scenario

Chapter 8 Molecular Cytogenetics Market: Competitive Landscape

• 8.1 Company Categorization
• 8.2 Strategy Mapping
  • 8.2.1 New Product Launch
  • 8.2.2 Partnerships
  • 8.2.3 Acquisition
  • 8.2.4 Collaboration
  • 8.2.5 Funding
• 8.3 Company Market Share Analysis, 2024
• 8.4 Company Profiles
  • 8.4.1 Bioview
    • 8.4.1.1 Company Overview
    • 8.4.1.2 Financial Performance
    • 8.4.1.3 Product Benchmarking
    • 8.4.1.4 Strategic Initiatives
  • 8.4.2 Danaher
    • 8.4.2.1 Company Overview
      • 8.4.2.1.1 Leica Biosystems Nussloch Gmbh
    • 8.4.2.2 Financial Performance
    • 8.4.2.3 Product Benchmarking
    • 8.4.2.4 Strategic Initiatives
  • 8.4.3 Metasystems
    • 8.4.3.1 Company Overview
    • 8.4.3.2 Financial Performance
    • 8.4.3.3 Product Benchmarking
    • 8.4.3.4 Strategic Initiatives
  • 8.4.4 Agilent Technologies, Inc.
    • 8.4.4.1 Company Overview
    • 8.4.4.2 Financial Performance
    • 8.4.4.3 Product Benchmarking
    • 8.4.4.4 Strategic Initiatives
  • 8.4.5 Abbott
    • 8.4.5.1 Company Overview
    • 8.4.5.2 Financial Performance
    • 8.4.5.3 Product Benchmarking
    • 8.4.5.4 Strategic Initiatives
  • 8.4.6 Bio-Rad Laboratories, Inc.
    • 8.4.6.1 Company Overview
    • 8.4.6.2 Financial Performance
    • 8.4.6.3 Product Benchmarking
    • 8.4.6.4 Strategic Initiatives
  • 8.4.7 Illumina, Inc.
    • 8.4.7.1 Company Overview
    • 8.4.7.2 Financial Performance
    • 8.4.7.3 Product Benchmarking
    • 8.4.7.4 Strategic Initiatives
  • 8.4.8 Oxford Gene Technology Ip Limited
    • 8.4.8.1 Company Overview
    • 8.4.8.2 Financial Performance
    • 8.4.8.3 Product Benchmarking
    • 8.4.8.4 Strategic Initiatives
  • 8.4.9 F. Hoffmann-La Roche Ltd
    • 8.4.9.1 Company Overview
      • 8.4.9.1.1 Genentech, Inc.
    • 8.4.9.2 Financial Performance
    • 8.4.9.4 Product Benchmarking
    • 8.4.9.5 Strategic Initiatives
  • 8.4.10 Perkinelmer Inc.
    • 8.4.10.1 Company Overview
    • 8.4.10.2 Financial Performance
    • 8.4.10.3 Product Benchmarking
    • 8.4.10.4 Strategic Initiatives